Monroe Capital (NASDAQ:MRCC – Free Report) had its target price trimmed by Oppenheimer from $9.00 to $8.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a market perform rating on the financial services provider’s stock.
Several other brokerages have also issued reports on MRCC. B. Riley lowered shares of Monroe Capital from a “neutral” rating to a “sell” rating and set a $7.25 price target on the stock. in a report on Wednesday, December 11th. StockNews.com lowered shares of Monroe Capital from a “buy” rating to a “hold” rating in a report on Monday.
View Our Latest Analysis on MRCC
Monroe Capital Trading Down 4.5 %
Monroe Capital Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 12.29%. The ex-dividend date is Friday, March 14th. Monroe Capital’s payout ratio is 166.67%.
Institutional Investors Weigh In On Monroe Capital
Large investors have recently made changes to their positions in the company. Private Advisor Group LLC bought a new stake in shares of Monroe Capital in the 3rd quarter worth about $104,000. Strategic Financial Concepts LLC bought a new stake in shares of Monroe Capital in the 4th quarter worth about $144,000. HB Wealth Management LLC grew its holdings in shares of Monroe Capital by 3.0% in the 4th quarter. HB Wealth Management LLC now owns 56,600 shares of the financial services provider’s stock worth $481,000 after purchasing an additional 1,650 shares during the last quarter. Magnolia Capital Advisors LLC grew its holdings in shares of Monroe Capital by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 102,555 shares of the financial services provider’s stock worth $872,000 after purchasing an additional 1,916 shares during the last quarter. Finally, Aspiriant LLC lifted its position in Monroe Capital by 18.2% during the 4th quarter. Aspiriant LLC now owns 13,000 shares of the financial services provider’s stock worth $110,000 after buying an additional 2,000 shares in the last quarter.
About Monroe Capital
Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants.
Recommended Stories
- Five stocks we like better than Monroe Capital
- How Investors Can Find the Best Cheap Dividend Stocks
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Compound Interest and Why It Matters When Investing
- Tesla Stock: Finding a Bottom May Take Time
- 3 Small Caps With Big Return Potential
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Monroe Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monroe Capital and related companies with MarketBeat.com's FREE daily email newsletter.